Salix Will Need To Dissolve Metozolv ODT Convenience Claims With Corrective Advertising Campaign; FDA Warning Letter Silent On REMS
• By The Pink Sheet
An effort by Salix Pharmaceuticals to tout advantages for its orally disintegrating metoclopramide product Metozolv ODT has ended with a need to run a corrective advertising campaign
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
